New Drugs 2016

Activity Preview 

Is newer better? Get to know all the new medications approved and first marketed in 2016 and compare them with pre-existing agents with similar indications. You’ll hear overviews of all the new therapeutic agents, indications for use, routes of administration, associated precautions, and the role these new drugs play in therapy. Patient education tips and practical monitoring considerations will also be discussed.

Activity Type: Knowledge-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: Level 2

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

1. List new therapeutic agents that were approved by the U.S. Food and Drug Administration and first marketed during 2016.
2. Describe the mechanisms of action and indications for new therapeutic agents first marketed in 2016.
3. Summarize adverse effects and patient safety considerations for new therapeutic agents first marketed in 2016.
4. Compare and contrast the new therapeutic agents first marketed in 2016 with products available with similar indications.
5. Discuss important patient education and therapeutic monitoring parameters for the new therapeutic agents.

At the completion of this activity, the pharmacy technician will be able to:

1. List new therapeutic agents that were approved by the U.S. Food and Drug Administration and first marketed during 2016.
2. Describe the mechanisms of action and indications for new therapeutic agents first marketed in 2016.
3. Summarize adverse effects and patient safety considerations for new therapeutic agents first marketed in 2016.
4. Compare and contrast the new therapeutic agents first marketed in 2016 with products available with similar indications.
5. Discuss important patient education and therapeutic monitoring parameters for the new therapeutic agents.

Accreditation Information 

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The following webinar is approved for 1.5 contact hour of CPE credit (0.15 CEUs). The ACPE Universal Activity Numbers for this activity are 0202-0000-17-141-L01-P and 0202-0000-17-141-L01-T.

To obtain credit for attending “New Drugs 2016, participants must attend the live activity, complete an evaluation, and CLAIM credit. An attendance code and detailed instructions of how to claim credit will be provided during the webinar. Participants will need to have a valid pharmacist.com username and password to claim credit. Please visit CPE monitor for your transcript of CPE. 

Initial Release Date: June 29, 2017 

Expiration Date: September 30, 2017 

Development

“New Drugs 2016” is a live, virtual continuing education activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association..

Support

This activity is supported by an independent educational grant from Janssen Scientific Affairs, LLC.

Disclosures

Daniel Hussar, BSPharm, MS, PhD, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures . 

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 

Activity Fee

There is no fee for this live activity. 

System Requirements

Computer and Internet access is required to complete this activity.  Please visit our website to view the System Requirements to have a positive learning experience.

New Drugs 2016

Date 6/29/2017 3:00:00 PM
Address 1125 Trenton-Harbourton Road
City Titusville State New Jersey Zip Code 20037